Orange Book product · Generic (ANDA)
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
At a glance
Oct 06, 2010
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 06, 2010
15 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Strength
12.5MG;50MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 077948
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- 1995HYZAARBrand (NDA)
NDA 020387 · ORGANON
- 2026LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 219869 · HETERO LABS LTD V
- 2023LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 218015 · GRANULES
- 2017LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 204901 · PRINSTON INC
- 2017LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 204832 · UNICHEM
- 2013LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 201682 · IPCA LABS LTD
- 2012LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 201845 · JUBILANT CADISTA
- 2012LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202289 · MACLEODS PHARMS LTD
- 2012LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 091617 · ALEMBIC PHARMS LTD
- 2011LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 200180 · WATSON LABS
- 2010LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090150 · APOTEX
- 2010LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 091629 · AUROBINDO PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
